Comprehensive weight loss + Enhanced lifestyle changes + Naltrexone-Bupropion + Phentermine-Topiramate for obesity

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 1 Mar 2025: Trial started, NCT06854614
  2. 3 Mar 2025: Trial registered, NCT06854614

The trials

NCT06854614: Sequential Therapy Anti-obesitY Medication With Muscle Preservation for Weight Loss and MaintEnance: A PragmAtic Randomized CoNtrolled Trial (STAY-LEAN Trial)

State
Under way
Phase
Phase 4
People
150 taking part
Started
1 Mar 2025
Primary completion
28 Apr 2027
Arms
Group 1 AOM
Results
None posted
  1. 1 Mar 2025: Trial started
  2. 3 Mar 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.